AlphaYouKG
Insider selling
Kathryn Guarini sold $320K of Regeneron Pharmaceuticals, Inc. (REGN) stock
Kathryn Guarini, Dir of Regeneron Pharmaceuticals, Inc. (REGN), sold 400 shares of REGN stock worth $320K, per an SEC Form 4 filed Aug 12, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 10, 2026, 2 days before it was made public.
REGN has moved -0.5% since the trade date, from $808.05 to $803.90 (Sep 22, 2026 close).
- Traded
- Aug 10, 2026
- Disclosed
- Aug 12, 2026
- Filing delay
- 2 days
- Price since
- -0.5%
- Role
- Dir
- Source
- SEC Form 4
More REGN insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.